pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
COMPANY OVERVIEW
Capella Bioscience is using innovative technologies to develop novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.
LOCATION
London, , UK
THERAPEUTIC AREAS
Autoimmune Disease
Oncology
WEBSITE
https://www.capellabioscience.com/
CAREER WEBSITE
None
SOCIAL MEDIA
INVESTORS
PRESS RELEASES
Mar 8, 2016
Capella Bioscience Completes Series A Financing of £11 million ($15.5 million) to Progress Antibody Pipeline
For More Press Releases